Special instructions and precautions:
Before starting treatment with tamsulosin it is necessary to verify the diagnosis. The patient should be examined in order to exclude the presence of other diseases that can cause the same symptoms as benign prostatic hyperplasia. Is necessary to exclude carcinoma (cancer) prostate cancer. Before starting treatment and regularly during therapy with tamsulosin should be performed digital rectal examination and, if required, the definition of prostate specific antigen (PSA).
As with other alpha 1-blockers in the treatment of tamsulosin in some cases there may be a decrease in blood pressure, which can sometimes lead to fainting. Tamsulosin should be used with caution in patients with a predisposition to orthostatic hypotension. At the first signs of orthostatic hypotension (dizziness, weakness) the patient should sit down or lay and leave in this position until the symptoms of this condition will not disappear.
Be wary appoint patients with Tamsulosin severe hepatic impairment and decreased creatinine clearance below 10 ml / min. In patients with impaired renal function do not require dose reduction of tamsulosin.
This medicine is generally not recommended in patients with a history of micturition syncope and in combination with other alpha1 blockers (see Interactions: alfuzosin, prazosin, terazosin, urapidil).